Skip to Content
  • 3.5
    Impact Factor
  • 5.1
    CiteScore
  • 28 days
    Submission to First Decision
  • 3 days
    Acceptance to Publication

Pathophysiology

Pathophysiology is an international, peer-reviewed, open access journal on the etiology, development, and elimination of pathological processes, published quarterly online by MDPI (since Volume 21, Issue 1 - 2020). The International Society for Pathophysiology (ISP) is affiliated with Pathophysiology, serving as its official journal. Society members receive discounts on the article processing charges.
  • Open Access— free for readers, with article processing charges (APC) paid by authors or their institutions.
  • High Visibility: indexed within ESCI (Web of Science), Scopus, PMC, PubMed, and other databases.
  • Journal Rank: JCR - Q1 (Pathology) / CiteScore - Q1 (Pathology and Forensic Medicine).
  • Rapid Publication: manuscripts are peer-reviewed and a first decision is provided to authors approximately 27.7 days after submission; acceptance to publication is undertaken in 2.9 days (median values for papers published in this journal in the first half of 2026).
  • Recognition of Reviewers: Reviewers whose reports are timely and of high quality receive an APC discount voucher for a future publication in an MDPI journal. Become a reviewer.

Get Alerted

Add your email address to receive forthcoming issues of this journal.

All Articles (357)

  • Article
  • Open Access

Background: Metabolic syndrome (MetS) is a complex systemic disorder involving metabolic dysfunction, chronic low-grade inflammation, and increased cardiovascular risk. Hematological alterations may reflect these systemic disturbances and could provide easily accessible markers of disease progression and response to intervention. This study investigated the effects of a high-fat diet (HFD) and subsequent calorie restriction (CR) on hematological parameters and derived inflammatory indices while exploring the potential involvement of AMP-activated protein kinase (AMPK) signaling. Methods: Eight-week-old male Wistar-Kyoto rats were divided into four groups (n = 9–10/group): CTRL, standard diet for 10 weeks; HFD, 42% high-fat diet for 10 weeks; HFD-CR, 6 weeks of HFD followed by 4 weeks of CR (20% for 2 weeks and 35% for last 2 weeks); and HFD-CR-CC, the same HFD-CR protocol combined with Compound C (1.5 mg/kg, i.p., twice weekly during CR) to inhibit AMPK. Metabolic and biometric parameters, as well as complete blood count (CBC), were recorded. Derived inflammatory indices were calculated from CBC values. Results: HFD induced metabolic alterations accompanied by CBC changes including changes in leukocyte profiles, decreased erythrocyte parameters (erythrocyte count, hematocrit, and hemoglobin concentration), and altered platelet indices. CR reversed some of these changes. AMPK inhibition during CR decreased the proportion of lymphocytes, increased neutrophil counts, and elevated derived inflammatory indices. Conclusions: Results suggest that routine hematological indices may serve as accessible markers of metabolic dysfunction and response to dietary intervention. AMPK may contribute to CR-induced changes in leukocyte profiles. Further investigation of hematological markers might enable earlier diagnosis and more personalized management of MetS.

Pathophysiology

21 November 2026

Experimental design. Abbreviations: CTRL—control rats fed a standard diet for 10 weeks; HFD—rats fed a high-fat diet for 10 weeks; HFD-CR—rats fed a high-fat diet for 6 weeks followed by 4 weeks of calorie restriction (CR); HFD-CR-CC—rats fed a high-fat diet for 6 weeks followed by 4 weeks of calorie restriction and Compound C (CC) treatment. Calorie restriction was induced in two steps. First, from week 6, the diet was switched from HFD to standard laboratory chow, while food intake was not restricted, resulting in a 20% reduction in energy intake. Second, from week 8, calorie restriction was further intensified by providing a weighed amount of standard chow corresponding to a 35% reduction in energy intake.
  • Article
  • Open Access

Ferritin Heavy Chain Is Increased in Patients with Advanced Melanoma

  • Sara Santos Bernardes,
  • Gabriella Pasqual-Zainzinger and
  • Sander Bekeschus
  • + 4 authors

Background: This study investigates the interplay between ferritin heavy chain (FHC), p53, and systemic oxidative stress in melanoma patients. Methods: Patients (57 enrolled, 49 analyzed for immunohistochemistry) and tumor samples were categorized into three groups: low metastasis risk (cutaneous melanoma, Breslow thickness < 2 mm), high metastasis risk (Breslow > 2 mm), and metastatic melanoma. Systemic oxidative stress was evaluated via erythrocyte lipid peroxidation, while serum ferritin heavy and light chain (FHC and FLC, respectively) levels were measured using ELISA. Tumor p53 expression and 3-nitrotyrosine (3-NT) occurrence were analyzed via immunohistochemistry. Results: Serum FHC levels and the FHC:FLC ratio were elevated in melanoma patients compared to controls, with the highest and significant FHC increases seen in the high-risk (>2 mm) and metastatic groups. This increase aligned with elevated systemic oxidative stress parameters. While FHC and 3-NT were expressed consistently across all tumor stages, p53 expression was significantly higher in the metastatic group than in the low-risk group. Conclusions: Patients with thick cutaneous melanomas (>2 mm) and metastatic disease share common biological processes, highlighting a significant interplay between FHC, systemic oxidative stress, and p53 expression in melanoma progression.

Pathophysiology

20 November 2026

Study scheme.
  • Review
  • Open Access

Autism spectrum disorder (ASD) arises from genetic susceptibility acting together with malleable environmental exposures, with special sensitivity during fetal and early postnatal critical periods. This narrative review (original literature search performed on 1 September 2026, with a follow-up search on 31 October 2026) covers three linked exposure groups: micro/nanoplastics (MNPs), the endocrine-disrupting chemicals (EDCs) that accompany plastics, and tire wear particles together with their transformation product 6PPD-quinone. We pay particular attention to immune and gut–microbial routes toward neuroinflammation. MNPs have been detected in human placenta, the brain, and breast milk, although reported concentrations differ widely between methods and studies, and one small human study links placental microplastic burden to shifted cord blood hormone levels, whereas placental DNA damage has been reported only in experimental models. In rodents and brain organoids, early-life exposure is associated with disturbed cortical layer formation and microglial synaptic pruning and in mice with autism-like behaviors, but that model is not equivalent to clinical ASD. Associations of phthalates, bisphenol A, and organophosphate esters with autistic traits differ by sex; for bisphenol A, human cohort data and mouse experiments together outline a route from reduced aromatase activity to amygdala dysfunction. In pregnant mice, 6PPD-quinone crosses the placenta and engages nuclear receptor signaling. Plastic exposure has also been linked to altered gut microbial composition. We build on our earlier hypothesis that such changes, which may resemble the dysbiosis described in ASD, add to oxidative stress by lowering microbial folate/B vitamin production and weakening short-chain-fatty-acid-mediated anti-inflammatory protection. We combine these mechanisms into one convergent framework, grade the evidence, and identify research priorities. Because most data are preclinical or associational, the framework is hypothesis-generating and does not show that plastic exposure causes ASD in humans.

Pathophysiology

19 November 2026

Schematic showing how MNPs, plastic-associated EDCs, tire wear particles/6PPD-quinone, and gut microbiome disturbance converge on disrupted neurodevelopment. Adapted from our previous schematic [20] and updated with the present findings. Solid arrows indicate hypothesized exposure-driven pathways, and the dashed arrow indicates genetic or immune modifiers that may interact with exposure; no arrow implies an established causal relationship in humans. Abbreviations: 6PPD-Q, 6PPD-quinone; ASD, autism spectrum disorder; CYP19A1, cytochrome P450 family 19 subfamily A member 1 (aromatase gene); EDCs, endocrine-disrupting chemicals; FRα, folate receptor alpha; MTHFR, methylenetetrahydrofolate reductase; NF-κB, nuclear factor kappa-light-chain-enhancer of activated B cells; RARα, retinoic acid receptor alpha; RXRα, retinoid X receptor alpha; SCFA, short-chain fatty acid; TBR1, T-box brain protein 1; TLR4, Toll-like receptor 4; ↑, increased; ↓, decreased.
  • Article
  • Open Access

Background: The endothelium plays a critical role in the development of atherosclerosis. Additionally, consumption of saturated fatty acids is linked to atherosclerosis and endothelial dysfunction. However, the overall transcriptomic response of endothelial cells following saturated fat exposure has yet to be fully characterized. Thus, we aimed to identify the molecular pathways linked to atherosclerosis in palmitate-treated endothelial cells through a secondary transcriptomic analysis. Methods: RNA-sequencing data from human umbilical vein endothelial cells (HUVECs), treated with BSA control or 100 μM of palmitic acid (3 replicates per group), were analyzed using DESeq2 through GEO2R. Genes with a Benjamini–Hochberg-adjusted p value < 0.05 and absolute log2 fold change > 0.58 were evaluated for pathway overrepresentation using STRING and Reactome. Results: Treatment with palmitic acid resulted in 259 significantly upregulated genes and 37 downregulated genes. The primary pathway analysis focused on the upregulated genes biologically associated with atherosclerotic processes. Specifically, prominent changes in transcriptional activity were seen in genes directly associated with antioxidant defense, inflammation, angiogenic regulation, and apoptosis based on pathway enrichment analysis. Conclusions: These findings identify candidate molecular mechanisms through which palmitic acid may contribute to endothelial dysfunction and atherogenesis.

Pathophysiology

19 November 2026

Palmitic acid treatment significantly upregulated genes associated with antioxidant defense in HUVECs. The levels of gene expression (measured in sample-level counts per million) were compared between BSA-treated control HUVEC samples and palmitate-treated HUVEC samples. Gene expression of the NRF2-associated antioxidant defense genes TXNRD1 (A), GCLM (B), SRXN1 (C), and SLC7A11 (D) was significantly increased following exposure to palmitic acid. On the other hand, the pro-oxidative genes NOX4 (E), NOXA1 (F), DUOX1 (G), and NOXO1 (H) did not show statistically significant changes in expression. These genes were included as comparison genes. Specifically, they were used to assess whether genes involved in NADPH oxidase-mediated ROS production showed significant transcriptional changes following palmitic acid exposure. However, the absence of significant changes in their expression does not rule out NADPH oxidase-derived ROS or establish mitochondrial ROS as the source. Data are expressed as mean ± SD from 3 replicates. Nominal p values are shown for NOXA1 and NOXO1 because adjusted p values were unavailable.

Highly Accessed Articles

News & Conferences

Latest Issues

Open for Submission

Journal Sections

XFacebookLinkedIn
Pathophysiology - ISSN 1873-149X